From 25 to 27 March 2025, the GLIOMATCH consortium convened in Düsseldorf, Germany, for its third consortium meeting. The meeting was held in-person and hosted by the partner University of […]
The 4th GLIOMATCH consortium meeting is held online on 17 November 2025 and focuses on scientific discussions and stakeholder involvement, including the distribution of the GLIOMATCH patient survey.
Make your plans to attend the 7th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies, held in conjunction with the 30th Society for Neuro-Oncology Annual Meeting & Education Day […]
Innovating Novel Combination Therapies & Maximising Preclinical & Clinical Development to Improve Glioblastoma Targeting & Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in Need The glioblastoma drug […]
The 2nd annual meeting of the U-THI-Clust is held in Warsaw, Poland and hosted by HIT-GLIO at the Nencki Institute.
From 27 to 29 of March 2026, the GLIOMATCH consortium will meet in Barcelona, Spain, for its fourth consortium meeting held in person. Details TBD.
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances […]
The 5th Consortium Meeting is held in Barcelona, Spain and organised by SJD.